Medivir AB (publ) Long Term Debt

Medivir AB (publ) (MVRBF) currently reports a long-term debt of $13M as of December 2022. That compares with $13M in the prior-year period — up 3.4% year over year. Use the charts on this page to explore Medivir AB (publ)'s long-term debt history and peer comparisons.

Medivir AB (publ)'s long-term debt increased from $13M to $13M — a 3.4% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medivir AB (publ) reported $13M in long-term debt as of December 2022. That compares with $13M in the prior-year period — up 3.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medivir AB (publ), and consider following MVRBF for alerts when major investors trade the stock.

Medivir AB (publ) is classified in the Healthcare sector. On long-term debt, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MVRBF with unrelated industries.